Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-02-29
1985-04-23
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514825, A61K 3146
Patent
active
045129967
ABSTRACT:
Pharmaceutical formulation containing benzoylecgonine and/or benzoylnorecgonine and their use in the treatment of rheumatoid arthritis are disclosed.
REFERENCES:
S. J. Mule et al., Life Sciences, 19, pp. 1585-1596 (1976).
Misra et al., Research Comm. in Chemical Pathology & Pharmacology, 13, pp. 579-584 (1976), +11, pp. 663-666 (1975).
Misra et al., J. Pharm. Pharmoc. 27, pp. 784-786 (1975).
Ann. Rev. Pharmacol. Toxical., 1979, 19:469-490, CA 83 172831b.
Research Communications in Chemical Pathology and Pharmacology, vol. 11, No. 4, Aug. 1975.
Medical World News, Long-Shot Hyperbaric Therapy Sets New Record, pp. 19-20, Oct. 15, 1979.
Arthritis News Today, Esterene in the Treatment of Rheumatoid Arthritis, vol. 2, No. 7, Apr. 1980.
LandOfFree
Benzoylecgonine or benzoylnorecgonine as active agents for the t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoylecgonine or benzoylnorecgonine as active agents for the t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoylecgonine or benzoylnorecgonine as active agents for the t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36763